LORRAINE STEVENS: Open Payments
NPI 1740585272 · SURPRISE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$320 in 12 payments from 9 companies in 2025. Trend: 2023 $187 · 2024 $270 · 2025 $320
Food & beverage: $320
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $135 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Novo Nordisk Inc | 2 | $34 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $25 |
| PFIZER INC. | 1 | $20 |
| Amgen Inc. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
| Exact Sciences Corporation | 1 | $14 |
Products named: WATCHMAN FLX, LifeVest, PREVNAR 20, FARXIGA, OTEZLA, TRELEGY ELLIPTA, QULIPTA, BREZTRI.
Industry payments across AZ — which companies pay providers there.
